Table 3.
Complications and mortality | Pre-pandemic (n = 197) | Pandemic (n = 287) | p value |
---|---|---|---|
Occurrence of postoperative complications | 45 (22.8%) | 105 (36.6%) | 0.002 |
In-hospital complications | |||
Urinary tract infection | 27 (13.7%) | 64 (22.3%) | 0.024 |
Pneumonia | 10 (5.1%) | 13 (4.5%) | 0.952 |
Sepsis/septic shock | 2 (1.0%) | 15 (5.2%) | 0.026 |
Acute renal failure | 5 (2.5%) | 9 (3.1%) | 0.913 |
Heart failure | 1 (0.5%) | 4 (1.4%) | 0.653 |
COPD with exacerbation | 0 (0.0%) | 1 (0.3%) | 1.000 |
Deep vein thrombosis | 1 (0.5%) | 2 (0.7%) | 1.000 |
Pulmonary embolism | 0 (0.0%) | 2 (0.7%) | 0.516 |
Gastrointestinal bleeding | 1 (0.5%) | 2 (0.7%) | 1.000 |
Acute myocardial infarction | 2 (1.0%) | 2 (0.7%) | 1.000 |
Stroke | 1 (0.5%) | 1 (0.3%) | 1.000 |
In-hospital mortality | 3 (1.4%) | 7 (2.3%) | 0.747 |
3-month mortality | 10 (4.8%) | 14 (4.6%) | 1.000 |
Data presented as mean ± standard deviation or number and percentage
A p value < 0.05 indicates statistical significance
Abbreviation: COPD, chronic obstructive pulmonary disease